Breaking News on Contract Research, Manufacturing & Clinical Trials

News headlines > Contract Manufacturing

News in brief

Vetter moves US sales office to Illinois “hotspot”

02-Sep-2010 - CMO Vetter Pharma has set up a US sales office in Skokie, Illinois to attract customers in growing Midwest drug industry hub.

BI opens ‘Centre of Competence’ opens as part of a €100m China plan

02-Sep-2010 - Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.

RecipharmCobra gets patents for yield-boosting plasmid tech

01-Sep-2010 - RecipharmCobra Biologics has received US and EU patent protection for an antibiotic resistance gene-free plasmid maintenance technology it claims can boost biomanufacturing yields.

News in brief

ScinoPharm Taiwan to invest in U.S. Tanvex Biologics

01-Sep-2010 - ScinoPharm, a Taiwan-based API maker invested Tanvex Biologics, expanding presence in US biosimilars contracting market.

Ricerca Biosciences completes cGMP Prep HPLC purification

31-Aug-2010 - Ricerca Biosciences say newly developed HPLC process offers drug firms API production that surpasses regulatory purity guidelines.

News in brief

Catalant wins Ph III "labelling and kitting" contract

26-Aug-2010 - Catalent Pharma Solutions has landed a “labelling and kitting” supply contract for a Ph III trial of Sunesis Pharmaceuticals’ candidate acute myeloid leukemia (AML) treatment vosaroxin.

Disposable manufacturing drives CMC’s Seattle expansion plans

26-Aug-2010 - A fully-equipped disposable manufacturing facility has been added to CMC Biologic’s Seattle, WA site, as the first stage of a major expansion plan.

News in brief

Biotech adds new primary packing suite

25-Aug-2010 - Biotec Services International has opened a new primary packaging suite tablet and capsule filling suite to cater for demand for “just in time” Ph I and Ph II trial supplies.

Stirling Pharma’s Canadian production plant to open by late September

25-Aug-2010 - Stirling Pharma’s state-of-the-art Canadian plant will open its doors in late September, and first to come off the production line will be the drug, acetaminophen.

Chemir launches ‘Custom Synthesis’ designer compound service

23-Aug-2010 - Chemir Analytical Services launches custom synthesis service for organic molecules for drug R&D, aimed at small pharma companies with rush or emergency projects.

SAFC and Novozymes Biopharma extend partnership in exclusive growth hormone distribution

19-Aug-2010 - SAFC and Novozymes Biopharma have agreed to extend their partnership by ten years for the exclusive distribution of LONG R3 growth factor, used for industrial cell culture applications.

News in brief

Lonza licenses skin substitute technology to Regenicin

19-Aug-2010 - Lonza has licensed the worldwide marketing rights for its tissue-engineering skin substitute technology to Regenicin.

News in brief

CMO opposing construction of apartments near production site

18-Aug-2010 - CMO BioVectra is appealing against a building permit for residential property near its facility, according to CBC News.

Aesica plans £3m high potency expansion

18-Aug-2010 - Aesica will build a “high containment” manufacturing plant to expand its high potency drug formulation capabilities in line with growing demand.

Patheon partners with TraceLink to boost production efficiency

17-Aug-2010 - Patheon is partnering with TraceLink to increase manufacturing efficiencies through closer integration and collaboration with clients.

Quay lands trial manufacturing deal with Japanese pharma

17-Aug-2010 - A Japanese pharmaceutical company has contracted UK-based Quay Pharma to make trial stocks of two NCEs used to treat genitourinary disorders. One of the products will be entering the first phase of its clinical studies in Europe, while the second is progressing to Phase II.

News in brief

Clodalkin plans pharma biz growth

16-Aug-2010 - Clondalkin aims to expand its pharmaceutical cartoning and labelling business with reorganised operations in Ireland and Poland.

EMA, FDA seek applicants for joint GMP inspections

16-Aug-2010 - The EMA and FDA are seeking pharma manufacturers to participate in a joint GMP (good manufacturing practice) inspection pilot programme.

News in brief

Xcelience installs tablet press

12-Aug-2010 - Xcelience has installed a Piccola B10 Minipress to expand its formulation development and manufacturing capabilities.

Elan halts EDT sale, again; AD drug into Ph III

11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”

Synthetech says revs down in Q1; unveils plans to expand

10-Aug-2010 - Lower overseas demand from key customers hurt fine chemicals maker Synthetech in first quarter fiscal 2011, continuing the decline seen in the previous financial year

News in brief

SCM wins new Sanofi fill/finish deal

09-Aug-2010 - SCM Pharma wins another deal with French drug giant Sanofi-Aventis.

AMRI posts $6m operating loss in Q2; plans expansions

05-Aug-2010 - AMRI recorded a $6.0m (€4.6m) operating loss in the second quarter as restructuring charges and the lack of milestone payments offset contract service gains.

Norwich adds small-scale manufacuting capacity for formulators

05-Aug-2010 - Norwich Pharmaceuticals has added development-stage drug production to its offering with new dedicated non-GMP capacity at its New York plant.

News in brief

SCM launches sterility and endotoxin testing

04-Aug-2010 - SCM says addition of sterility and endotoxin analysis capacity is logical extension of its contract fill/finish offering.